IP Library Granted Patent US 12,054,702
Granted Patent B2
US 12,054,702 · App. 17/150,878 · Granted Aug 6, 2024

DNA vectors, transposons and transposases for eukaryotic genome modification

Inventors: Jeremy Minshull (Los Altos, CA); Mark Welch (Fremont, CA); Sridhar Govindrajan (Los Altos, CA); Maggie Lee (San Jose, CA); Kate Caves (San Jose, CA); Jon Ness (Redwood City, CA)
Assignee: DNA TWOPOINTO INC.
C12N1/165C12N1/185C12N9/12C12N9/1241C12N15/1082C12N15/52C12N15/625C12N15/63C12N15/81C12N15/815C12N15/85C12N15/8509C12N15/90C12Y207/00C12Y207/07C07K2319/09C12N15/67C12N2800/90C12N2830/007C12N2830/40C12N2830/42C12N2840/203C12R2001/84C12R2001/865
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,054,702
App. No.
17/150,878
Granted
Aug 6, 2024
Kind
B2
Abstract

The present invention provides polynucleotide vectors for high expression of heterologous genes. Some vectors further comprise novel transposons and transposases that further improve expression. Further disclosed are vectors that can be used in a gene transfer system for stably introducing nucleic acids into the DNA of a cell. The gene transfer systems can be used in methods, for example, gene expression, bioprocessing, gene therapy, insertional mutagenesis, or gene discovery.

Claims (7)

1. A polypeptide comprising a non-naturally occurring transposase with at least 90% sequence identity to the amino acid sequence of SEQ ID NO:407, wherein the transposase differs from the amino acid sequence of SEQ ID NO:407 at least by one or more of the following amino acid substitutions (numbered according to SEQ ID NO: 407): Q92A, V93L, V93M, P96G, F97H, F97C, H165E, H165W, E178S, E178H, C189P, A196G, L200I, L200M, A201Q, L211A, W215Y, T217K, G219S, Q235Y, Q235G, Q238L, K246I, K253V, M258V, F261L, S263K, C271S, N303R, F321W, F321D, V323T, V324K, V324H, A330V, Q333M, L373C, L373V, V389L, S399N, R402K, T403L, D404Q, D404S, D404M, N441R, G448W, E449A, V469T, C473Q, R484K, T507C, G523A, I527M, Y528K, Y543I, E549A, K550M, P557S, V567I, V567H, E601V, E605H, E605W, D607H, S609H or L610I, and the transposase has excision or transposition activity.

2. The polypeptide of claim 1 , wherein the transposase also differs from the amino acid sequence of SEQ ID NO:407 by at least one of the following amino acid substitutions: Q85E, Q85M, Q85K, Q85H, Q85N, Q85T, Q85F, Q85L, Q92E, Q92P, Q92N, Q92I, Q92Y, Q92H, Q92F, Q92R, Q92D, Q92M, Q92W, Q92C, Q92G, Q92L, Q92V, Q92T, V93P, V93K, V93F, V93W, V93A, V93I, V93Q, P96A, P96T, P96M, P96R, P96V, P96E, P96Q, P96C, F97Q, F97K, F97T, F97W, F97V, F97E, F97P, F97D, F97A, F97R, F97G, F97N, F97Y, H165G, H165Q, H165T, H165M, H165V, H165L, H165C, H165N, H165D, H165K, H165A, E178Y, E178F, E178C, E178A, E178Q, E178G, E178V, E178D, E178L, E178P, E178W, C189D, C189Y, C189I, C189W, C189T, C189K, C189M, C189F, C189Q, C189V, L200I, L200F, L200C, L200Y, A201L, A201M, L203V, L203D, L203G, L203E, L203C, L203T, L203M, L203A, L203Y, N207G, N207A, L211G, L211M, L211C, L211T, L211V, T217V, T217A, T2171, T217P, T217C, T217Q, T217M, T217F, T217D, G219A, G219C, G219H, G219Q, Q235C, Q235N, Q235H, Q235W, Q235A, Q235T, Q235E, Q235M, Q235F, Q238C, Q238M, Q238H, Q238V, Q238T, Q238I, R242Q, N303C, N303G, N303A, N303D, N303S, N303H, N303E, N303R, N303K, N303L, N303Q, I312F, I312C, I312A, I312L, I312T, I312V, I312G, I312M, F321H, F321R, F321N, F321Y, F321G, F321E, F321M, F321K, F321A, F321Q, V323I, V323L, V323M, V323A, V324N, V324A, V324C, V324I, V324L, V324T, V324Y, V324F, V324S, V324Q, V324M, V324G, A330K, A330P, A330S, A330C, A330T, A330L, Q333P, Q333T, Q333H, Q333S, P337W, P337E, P337H, P337I, P337A, P337M, P337N, P337D, P337K, P337Q, P337G, P337S, P337C, P337L, P337V, F368Y, L373I, L373S, L373T, V389I, V389M, V389T, V389A, R394H, R394K, R394T, R394P, R394M, R394A, Q395P, Q395F, Q395E, Q395C, Q395V, Q395A, Q395H, Q395S, Q395Y, S399E, S399K, S399H, S399D, S399Y, S399G, S399Q, S399R, S399T, S399A, S399V, S399M, R402Y, R402D, R402F, R402G, R402N, R402E, R402M, R402S, R402Q, R402T, R402C, R402L, R402V, T403W, T403A, T403V, T403F, T403Y, T403N, T403G, T403C, T403I, T403 S, T403M, T403Q, T403K, T403E, D404I, D404E, D404N, D404H, D404C, D404G, D404A, D404L, D404P, D404V, D404W, D404F, N408F, N408I, N408A, N408E, N408M, N408S, N408D, N408Y, N408H, N408C, N408Q, N408V, N408W, N408L, N408P, N408K, S409H, S409Y, S409N, S409I, S409D, S409F, S409T, S409C, S409Q, N441F, N441M, N441G, N441C, N441D, N441L, N441A, N441V, N441W, G448Y, G448H, G448C, G448T, G448V, G448N, G448Q, E449P, E449T, E449L, E449H, E449G, E449C, E449I, V469A, V469H, V469C, V469L, L472K, L472Q, L472M, C473G, C473T, C473I, C473M, R484H, T507R, T507D, T507S, T507G, T507K, T507I, T507M, T507E, T507L, T507V, G523Q, G523T, G523M, G523 S, G523C, G523I, G523L, I527V, Y528N, Y528W, Y528M, Y528Q, Y528V, Y528I, Y528G, Y528D, Y528A, Y528E, Y528R, Y543C, Y543W, Y543M, Y543Q, Y543A, Y543R, Y543H, E549K, E549C, E549I, E549Q, E549H, E549C, E549M, E549S, E549F, E549L, K550R, K550Q, S556G, S556V, S556I, P557W, P557T, P557A, P557Q, P557K, P557D, P557G, P557N, P557L, P557V, H559K, H559S, H559C, H559I, H559W, V560F, V560P, V560I, V560H, V560Y, V560K, N561P, N561Q, N561G, N561A, V562Y, V562I, V562S, V562M, V567N, S583M, E601F, E601Q, E601W, E605R, E605K, E605M, E605P, E605Y, E605C, E605A, E605Q, E605S, E605V, E605I, E605G, D607V, D607Y, D607C, D607N, D607W, D607T, D607A, D607Q, D607E, D607L, D607K, D607G, S609R, S609W, S609V, S609Q, S609G, S609T, S609K, S609N, S609Y, L610T, L610K, L610G, L610A, L610W, L610D, L610Q, L610S, L610F, or L610N.

3. The polypeptide of claim 1 , wherein the transposase comprises a sequence selected from one of the amino acid sequences of SEQ ID NO:409-697.

4. The polypeptide of claim 1 , wherein the transposase is fused to a heterologous nuclear localization sequence.

5. The polypeptide of claim 1 , wherein the transposase comprises the amino acid sequence of SEQ ID NO:415.

6. The polypeptide of claim 1 , wherein the transposase has at least 95% sequence identity to the amino acid sequence of SEQ ID NO:407.

7. The polypeptide of claim 1 , wherein the transposase has at least 97% sequence identity to the amino acid sequence of SEQ ID NO:407.

Continuity (5)
Division 15287622 · Oct 6, 2016
Provisional Application 62373422 · Aug 11, 2016
Provisional Application 62325872 · Apr 21, 2016
Provisional Application 62239109 · Oct 8, 2015
Related Publication 20210139919A1 · May 13, 2021